U.S. Markets closed

How Analysts View Alexion Pharmaceuticals Stock in October

Kenneth Smith
How Analysts View Alexion Pharmaceuticals Stock in October

In October, 18 analysts are covering Alexion Pharmaceuticals (ALXN) stock. Five of them have recommended a “strong buy,” 11 have recommended a “buy,” and two have recommended a “hold.”